Uploaded October 2025 | Updated September 2026, 1 week ago
This World Health Summit 2025 Global Health Lab session – co-hosted by Fresenius and the Hasso Plattner Institute (HPI) – explored how countries and stakeholders could better use existing evidence, data, and tools to strengthen antimicrobial resistance (AMR) policy implementation. The discussion focused on the persistent gap between growing global commitments and the practical steps required to turn these commitments into sustained action.
The session was moderated by Lothar H. Wieler (HPI). It examined how countries could improve the generation and strategic use of AMR data across sectors and how available tools and standards could support prioritization, planning, and evaluation. The conversation emphasized the importance of reliable surveillance data, evidence on effective interventions, and insights from field implementation to shape future AMR policy and investment decisions.
The Speakers, Mohsen Naghavi (Institute for Health Metrics and Evaluation, IHME), Arshnee Moodley (International Centre for Antimicrobial Resistance Solutions, ICARS), Ralf Kuhlen (Fresenius), and Kevin Outterson (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator, CARB-X) brought perspectives from global health metrics, livestock and environmental health, clinical care, and biopharmaceutical innovation. They discussed ways to strengthen accountability, improve decision-making, and support impactful AMR responses in low- and middle-income settings.
The session highlighted that better data, stronger coordination, and the effective use of existing tools were essential to advance AMR policy implementation and drive meaningful, long-term progress.
The World Health Summit is the leading global platform bringing together science, politics, civil society, and the private sector to catalyze collaborative and innovative solutions for key health priorities. Learn more: worldhealthsummit.org
This World Health Summit 2025 Global Health Lab session – co-hosted by Fresenius and the Hasso Plattner Institute (HPI) – explored how countries and stakeholders could better use existing evidence, data, and tools to strengthen antimicrobial resistance (AMR) policy implementation. The discussion focused on the persistent gap between growing global commitments and the practical steps required to turn these commitments into sustained action.
The session was moderated by Lothar H. Wieler (HPI). It examined how countries could improve the generation and strategic use of AMR data across sectors and how available tools and standards could support prioritization, planning, and evaluation. The conversation emphasized the importance of reliable surveillance data, evidence on effective interventions, and insights from field implementation to shape future AMR policy and investment decisions.
The Speakers, Mohsen Naghavi (Institute for Health Metrics and Evaluation, IHME), Arshnee Moodley (International Centre for Antimicrobial Resistance Solutions, ICARS), Ralf Kuhlen (Fresenius), and Kevin Outterson (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator, CARB-X) brought perspectives from global health metrics, livestock and environmental health, clinical care, and biopharmaceutical innovation. They discussed ways to strengthen accountability, improve decision-making, and support impactful AMR responses in low- and middle-income settings.
The session highlighted that better data, stronger coordination, and the effective use of existing tools were essential to advance AMR policy implementation and drive meaningful, long-term progress.
The World Health Summit is the leading global platform bringing together science, politics, civil society, and the private sector to catalyze collaborative and innovative solutions for key health priorities. Learn more: worldhealthsummit.org
